Optiver Holding
VRCA icon

Optiver Holding’s Verrica Pharmaceuticals VRCA Stock Holding History

Optiver Holding’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$164 Hold
31
– – ﹤0.01% 2227
2025
Q4 		$258 Hold
31
– – ﹤0.01% 2337
2025
Q3 		$134 Buy
+31
New +$187 ﹤0.01% 2589

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Optiver Holding's VRCA Position: Q1 2026 in Review

Optiver Holding held its Verrica Pharmaceuticals (VRCA) position steady in Q1 2026 at 31 shares worth $164. The position accounts for ﹤0.01% of the portfolio, ranked #2227.

Optiver Holding first reported a position in VRCA in Q3 2025 and has held it in 3 quarters since. The position peaked at $258 in Q4 2025. 39 funds tracked by Wall St. Rank hold VRCA as of Q1 2026.

  • Optiver Holding held 31 shares of Verrica Pharmaceuticals worth $164 as of Q1 2026.
  • Optiver Holding left its Verrica Pharmaceuticals share count unchanged in Q1 2026.
  • Verrica Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2227 holding.
  • Optiver Holding first reported a position in Verrica Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Verrica Pharmaceuticals position peaked at $258 in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.